Modified Blalock-Taussig shunts: To heparinize or not to heparinize?

Canadian Journal of Cardiology

Volumn 12, Issue 7, 1996, Pages 645-647

  Mullen, John C ^a   Lemermeyer, Gillian ^a   Bentley, Michael J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anticoagulant therapy; Heparin; Modified blalocke Taussig shunt; Shunt thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLALOCK TAUSSIG ANASTOMOSIS; CHEMOSURGERY; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; FEMALE; HEPARINIZATION; HUMAN; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; SURGICAL MORTALITY;

ANASTOMOSIS, SURGICAL; ANTICOAGULANTS; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEPARIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; POSTOPERATIVE COMPLICATIONS; PULMONARY ARTERY; SUBCLAVIAN ARTERY; THROMBOSIS; VASCULAR PATENCY;

EID: 0029778086     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Tamisier D, Vouhe PR, Vemant F, Leca F, Massor C, Neveux J. Modified Blalock-Taussig shunts: results in infants less than 3 months of age. Ann Thorac Surg 1990;49:797-801.
2. Guyton RA, Owens JE, Waumett JD, et al. The Blalock-Taussig shunt. Low risk, effective palliation and pulmonary artery growth. J Thorac Cardiovasc Surg 1983;85:917-22.
3. LeBlanc J, Albus R, William WG, et al. Serous fluid leakage: a complication following the modified Blalock-Taussig shunt. J Thorac Cardiovasc Surg 1984;88:259-62.
4. Bove EL, Kohman L, Sereika S, et al. The modified Blalock-Taussig shunt: analysis of adequacy and duration of palliation. Circulation 1987;76:III19-23.
5. Moulton AL, Brenner JI, Ringer R, et al. Classic versus modified Blalock-Taussig shunts in neonates and infants. Circulation 1985;72:1135-44.
6. Karpawich PP, Bush CP, Antillon JR, Amato JJ, Morbey ML, Agarwal KC. Modified Blalock-Taussig shunt in infants and young children: clinical and catheterization assessment. J Thorac Cardiovasc Surg 1985;89:275-9.
7. Maitland A, Williams WG, Coles JG, Freedom RM, Trusler GA. A method of treating serous fluid leak from a polytetrafluoroethylene Blalock-Taussig shunt. J Thorac Cardiovasc Surg 1985;90:791-3.
8. Noyez L, Daenen W. The modified polytetrafluoroethylene Blalock-Taussig shunt: case report of an unusual complication. J Thorac Cardiovasc Surg 1987;94:634-5.
9. Ölzkutlu S, Özbarlas N, Demircin M. Perigraft seroma diagnosed by echocardiography: a complication following Blalock-Taussig shunt. Int J Cardiol 1992;36:244-6.
10. Green RM, Roedersheimer R, DeWeese JA. Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Surgery 1982;92:1016-26.
11. Ware JA, Lewis J, Slazman EW. Antithromboric therapy. In: Rutherford RB, ed. Vascular Surgery. Philadelphia: WB Saunders, 1989:287-300.